Home > Press Releases > Infant Formula Market

Infant Formula Market Likely to Surpass ~USD 223 Billion by 2035

Report Code: FB-77952  |  Published in: Nov 2025, By MarketGenics  |  Number of pages: 434
Get PDF
Buy

Exploring novel growth opportunities on, “Infant Formula Market Size, Share & Trends Analysis Report by Product Type (Milk-based Formula, Soy-based Formula, Protein Hydrolysate Formula, Specialty Formula, Organic Formula, Follow-on Formula), Form, Stage/Age Group, Ingredient Type, Packaging Type, Distribution Channel, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” An In‑depth study examining emerging pathways in the infant formula market identifies critical enablers from localized R&D and supply-chain agility to digital integration and regulatory convergence positioning infant formula for sustained international growth

Global Infant Formula Market Forecast 2035:

According to the report, the global infant formula market is likely to grow from USD 64.5 Billion in 2025 to USD 222.9 Billion in 2035 at a highest CAGR of 13.2% during the time period. The global infant formula market is growing at a very fast pace as the requirements of scientifically developed, fortified and clinically tested infant foodstuffs are on the rise. The increase in parental awareness of the importance of nutrition and digestive health in infancy and immunity support has led to the popularity of formulas in bioactive peptides, prebiotics, probiotics, and essential micronutrients. The increasing investments in high-value and specialized infant formulas such as organic, allergen free and custom-made nutrition products are also contributing to the accelerating growth of the market in major areas.

High-level manufacturing and bioprocessing technologies are improving the efficiency of production and quality of products. High-throughput protein fractionation, precision fermentation, automated drying and blending systems allow manufacturers to optimize nutrient profiles, increase solubility and consistency across batches. New texturization, encapsulation and formulation techniques also enable the inclusion of sensitive components such as vitamins, minerals and HMOs to maintain stability and bioavailability besides enabling innovation in ready-to-feed, powder and modular formula products.

Alliances between ingredient companies, biotechnology companies, and producers of infant formula are increasing product range and accelerating market penetration. Strategic alliances aid in the incorporation of hi-tech ingredients, research provision, and production expansion without breaching regulations. These initiatives together with the increasing trends towards e-commerce distribution, health conscious consumers and governmental programs in encouraging baby health are driving up the global adoption and driving the long-term development of the infant formula market.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Infant Formula Market”

The global infant formula market is increasing due to increased consumer demand of individualized and accuracy nutritional food. Digital nutrition platforms, AI-assisted formulations, and biomarker-based customization are also allowing manufacturers to create products in different formulas that can address the unique nutritional requirements of infants, including digestive tolerance, growth support, and immunity enhancement. Also, growth of gut health and functional nutrition awareness is prompting parents to switch to fortified formulas that are enriched with prebiotics, probiotics and bioactive peptides that are broadening the infant formula innovation products market across the globe.

Operational and regulatory issues moderate market expansion. The expensive nature of advanced R&D, together with the strict clinical trial and approval processes, delays product launches. Local differences in labeling, safety, and fortification requirements and limited access to specialized ingredients are further challenges to manufacturers that seek to expand efficiently.

The market opportunities are presented by the combination of sustainable supply chains, strategic partnerships, and digital health platforms. Partnerships between infant formula producers, biotechnology companies and healthcare organizations improve product development, facilitate market penetration more quickly and make the product accessible to more consumers. Long-term growth potential can further be supported by growing urbanization, increasing disposable incomes, and premiumization trends in the emerging markets.

Infant Formula Market Growth Fueled by Product Innovation and Partnerships

  • The global infant formula market is booming as the demand of high quality, safe and scientifically based nourishment to the babies is increasing. To address the different nutritional needs, manufacturers are still launching new product lines to cater to special formula like hypoallergenic, hydrolyzed and fortified. The development of innovations in ingredients, manufacturing technologies and formulation science are improving the digestibility, nutrient retention, and the overall quality of products, making it possible to make the products more accepted by the consumer and expand them in the market.
  • The strategic alliances that are being established between formula manufacturers, ingredient suppliers/distribution channels are also speeding up the commercialization process and raising penetrations in the market. Alliances can be used to create the products faster, establish more effective supply chains, and bring new innovative infant formulas to the market. Combined with positive regulatory conditions, an increasing proportion of conscious consumers, and increasing demand in nutritious and functional nutrition, all these factors are compounding to the long-term performance of the infant formula industry worldwide.

Regional Analysis of Global Infant Formula Market

  • The Asia-Pacific region dominates the infant formula market due to high birth rates, increasing disposable incomes and important cultural emphasis on infant nutrition, the presence of well-established manufacturing and dairy-innovation hubs in industrialized countries such as China, Japan and South Korea. Premier infant formulas are emerging due to the rapid production of high-quality, fortified, and specialized infant formulas which is possible through advanced protein processing technologies, accuracy in fermentation, and the R&D of domestic ingredients. Commercialization and consumer adoption in the region is further accelerated by strategic partnerships, government-sponsored nutrition initiatives as well as increasing the number of e-commerce portals. Major firms are also undertaking the establishment of cold-chain and contemporary retailing infrastructure to access consumers in the urban and semi urban areas more effectively.
  • North America region is expanding at a very fast rate with a well-established bio manufacturing infrastructure, proliferation of pilot-scale manufacturing processes, and cellular agriculture research and development. The positive regulatory climate, general consumer sensitivity to infant nutrition, and the need to have convenient, science-based formulas are stimulating the rapid growth of the market in the area. In addition, the market is served by increasing attention to individualized nutrition and formula options based on the particular infant requirements, as hypoallergenic or protein-hydrolysate formula.

Prominent players operating in the global infant formula market are Abbott Laboratories, Arla Foods, Beingmate Baby & Child Food Co., Ltd., Bellamy's Organic, Biostime International Holdings Limited, China Feihe Limited, Dairy Farms International Holdings Ltd, Danone S.A., Fonterra Co-operative Group Limited, FrieslandCampina, Hain Celestial Group, HiPP GmbH & Co. Vertrieb KG, Inner Mongolia Yili Industrial Group, Meiji Holdings Co., Ltd., Morinaga Milk Industry Co., Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group plc, Synutra International Inc., The Kraft Heinz Company, Other Key Players.

The global infant formula market has been segmented as follows:

Global Infant Formula Market Analysis, By Product Type

  • Milk-based Formula
    • Cow Milk-based
    • Goat Milk-based
  • Soy-based Formula
  • Protein Hydrolysate Formula
    • Partially Hydrolyzed
    • Extensively Hydrolyzed
  • Specialty Formula
    • Lactose-free Formula
    • Hypoallergenic Formula
    • Anti-reflux Formula
    • Premature/Low Birth Weight Formula
    • Others
  • Organic Formula
  • Follow-on Formula

Global Infant Formula Market Analysis, by Form

  • Powder
  • Liquid Concentrate
  • Ready-to-Feed (RTF)

Global Infant Formula Market Analysis, by Stage/Age Group

  • Stage 1 (0-6 months)
  • Stage 2 (6-12 months)
  • Stage 3 (12-24 months)
  • Stage 4 (24+ months/Toddler)

Global Infant Formula Market Analysis, by Ingredient Type

  • Standard Ingredients
  • Added Prebiotics
  • Added Probiotics
  • DHA/ARA Fortified
  • Iron Fortified
  • Multi-nutrient Fortified

Global Infant Formula Market Analysis, by Packaging Type

  • Cans/Tins
  • Pouches
  • Cartons
  • Bottles (Ready-to-Feed)
  • Stick Packs

Global Infant Formula Market Analysis, by Distribution Channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Pharmacy/Drug Stores
  • Online Retail
    • E-commerce Platforms
    • Company Websites
  • Specialty Baby Stores
  • Hospital Pharmacies

Global Infant Formula Market Analysis, by End-users

  • Healthcare/Medical
    • Neonatal Intensive Care Units (NICU)
    • Pediatric Hospitals
    • Clinical Nutrition Management
    • Therapeutic Feeding Programs
    • Others
  • Retail/Consumer
    • Home/Household Consumption
    • Daily Nutrition
    • Supplementary Feeding
    • Travel/On-the-go Feeding
    • Others
  • Food Service
    • Daycare Centers
    • Nurseries
    • Childcare Facilities
    • Hospitality (Hotels with childcare)
    • Others
  • Institutional
    • Orphanages
    • Government Feeding Programs
    • NGO/Relief Programs
    • Maternity Care Centers
    • Others

Global Infant Formula Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Infant Formula Market Outlook
      • 2.1.1. Infant Formula Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2025-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Food & Beverages Industry Overview, 2025
      • 3.1.1. Food & Beverages Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Food & Beverages Industry
      • 3.1.3. Regional Distribution for Food & Beverages Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising awareness of infant nutrition and health benefits of formula
        • 4.1.1.2. Increasing working mothers and urbanization boosting formula demand
        • 4.1.1.3. Technological innovations in formulation and fortification (DHA, probiotics, prebiotics)
      • 4.1.2. Restraints
        • 4.1.2.1. High cost of premium infant formula products
        • 4.1.2.2. Strict regulatory compliance and safety standards
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Raw Material Sourcing
      • 4.4.2. Manufacturing & Production
      • 4.4.3. Distribution & Logistics
      • 4.4.4. Marketing & Sales
    • 4.5. Cost Structure Analysis
      • 4.5.1. Parameter’s Share for Cost Associated
      • 4.5.2. COGP vs COGS
      • 4.5.3. Profit Margin Analysis
    • 4.6. Pricing Analysis
      • 4.6.1. Regional Pricing Analysis
      • 4.6.2. Segmental Pricing Trends
      • 4.6.3. Factors Influencing Pricing
    • 4.7. Porter’s Five Forces Analysis
    • 4.8. PESTEL Analysis
    • 4.9. Global Infant Formula Market Demand
      • 4.9.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.9.2. Current and Future Market Size - Value (US$ Bn), 2025–2035
        • 4.9.2.1. Y-o-Y Growth Trends
        • 4.9.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Infant Formula Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Milk-based Formula
        • 6.2.1.1. Cow Milk-based
        • 6.2.1.2. Goat Milk-based
      • 6.2.2. Soy-based Formula
      • 6.2.3. Protein Hydrolysate Formula
        • 6.2.3.1. Partially Hydrolyzed
        • 6.2.3.2. Extensively Hydrolyzed
      • 6.2.4. Specialty Formula
        • 6.2.4.1. Lactose-free Formula
        • 6.2.4.2. Hypoallergenic Formula
        • 6.2.4.3. Anti-reflux Formula
        • 6.2.4.4. Premature/Low Birth Weight Formula
        • 6.2.4.5. Others
      • 6.2.5. Organic Formula
      • 6.2.6. Follow-on Formula
  • 7. Global Infant Formula Market Analysis, by Form
    • 7.1. Key Segment Analysis
    • 7.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Form, 2021-2035
      • 7.2.1. Powder
      • 7.2.2. Liquid Concentrate
      • 7.2.3. Ready-to-Feed (RTF)
  • 8. Global Infant Formula Market Analysis, by Stage/Age Group
    • 8.1. Key Segment Analysis
    • 8.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Stage/Age Group, 2021-2035
      • 8.2.1. Stage 1 (0-6 months)
      • 8.2.2. Stage 2 (6-12 months)
      • 8.2.3. Stage 3 (12-24 months)
      • 8.2.4. Stage 4 (24+ months/Toddler)
  • 9. Global Infant Formula Market Analysis, by Ingredient Type
    • 9.1. Key Segment Analysis
    • 9.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Ingredient Type, 2021-2035
      • 9.2.1. Standard Ingredients
      • 9.2.2. Added Prebiotics
      • 9.2.3. Added Probiotics
      • 9.2.4. DHA/ARA Fortified
      • 9.2.5. Iron Fortified
      • 9.2.6. Multi-nutrient Fortified
  • 10. Global Infant Formula Market Analysis, by Packaging Type
    • 10.1. Key Segment Analysis
    • 10.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Packaging Type, 2021-2035
      • 10.2.1. Cans/Tins
      • 10.2.2. Pouches
      • 10.2.3. Cartons
      • 10.2.4. Bottles (Ready-to-Feed)
      • 10.2.5. Stick Packs
  • 11. Global Infant Formula Market Analysis, by Distribution Channel
    • 11.1. Key Segment Analysis
    • 11.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 11.2.1. Supermarkets/Hypermarkets
      • 11.2.2. Convenience Stores
      • 11.2.3. Pharmacy/Drug Stores
      • 11.2.4. Online Retail
        • 11.2.4.1. E-commerce Platforms
        • 11.2.4.2. Company Websites
      • 11.2.5. Specialty Baby Stores
      • 11.2.6. Hospital Pharmacies
  • 12. Global Infant Formula Market Analysis, by End-users
    • 12.1. Key Segment Analysis
    • 12.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-users, 2021-2035
      • 12.2.1. Healthcare/Medical
        • 12.2.1.1. Neonatal Intensive Care Units (NICU)
        • 12.2.1.2. Pediatric Hospitals
        • 12.2.1.3. Clinical Nutrition Management
        • 12.2.1.4. Therapeutic Feeding Programs
        • 12.2.1.5. Others
      • 12.2.2. Retail/Consumer
        • 12.2.2.1. Home/Household Consumption
        • 12.2.2.2. Daily Nutrition
        • 12.2.2.3. Supplementary Feeding
        • 12.2.2.4. Travel/On-the-go Feeding
        • 12.2.2.5. Others
      • 12.2.3. Food Service
        • 12.2.3.1. Daycare Centers
        • 12.2.3.2. Nurseries
        • 12.2.3.3. Childcare Facilities
        • 12.2.3.4. Hospitality (Hotels with childcare)
        • 12.2.3.5. Others
      • 12.2.4. Institutional
        • 12.2.4.1. Orphanages
        • 12.2.4.2. Government Feeding Programs
        • 12.2.4.3. NGO/Relief Programs
        • 12.2.4.4. Maternity Care Centers
        • 12.2.4.5. Others
  • 13. Global Infant Formula Market Analysis and Forecasts, by Region
    • 13.1. Key Findings
    • 13.2. Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 13.2.1. North America
      • 13.2.2. Europe
      • 13.2.3. Asia Pacific
      • 13.2.4. Middle East
      • 13.2.5. Africa
      • 13.2.6. South America
  • 14. North America Infant Formula Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. North America Infant Formula Market Size Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Product Type
      • 14.3.2. Form
      • 14.3.3. Stage/Age Group
      • 14.3.4. Ingredient Type
      • 14.3.5. Packaging Type
      • 14.3.6. Distribution Channel
      • 14.3.7. End-users
      • 14.3.8. Country
        • 14.3.8.1. USA
        • 14.3.8.2. Canada
        • 14.3.8.3. Mexico
    • 14.4. USA Infant Formula Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Product Type
      • 14.4.3. Form
      • 14.4.4. Stage/Age Group
      • 14.4.5. Ingredient Type
      • 14.4.6. Packaging Type
      • 14.4.7. Distribution Channel
      • 14.4.8. End-users
    • 14.5. Canada Infant Formula Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Product Type
      • 14.5.3. Form
      • 14.5.4. Stage/Age Group
      • 14.5.5. Ingredient Type
      • 14.5.6. Packaging Type
      • 14.5.7. Distribution Channel
      • 14.5.8. End-users
    • 14.6. Mexico Infant Formula Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Product Type
      • 14.6.3. Form
      • 14.6.4. Stage/Age Group
      • 14.6.5. Ingredient Type
      • 14.6.6. Packaging Type
      • 14.6.7. Distribution Channel
      • 14.6.8. End-users
  • 15. Europe Infant Formula Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Europe Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Product Type
      • 15.3.2. Form
      • 15.3.3. Stage/Age Group
      • 15.3.4. Ingredient Type
      • 15.3.5. Packaging Type
      • 15.3.6. Distribution Channel
      • 15.3.7. End-users
      • 15.3.8. Country
        • 15.3.8.1. Germany
        • 15.3.8.2. United Kingdom
        • 15.3.8.3. France
        • 15.3.8.4. Italy
        • 15.3.8.5. Spain
        • 15.3.8.6. Netherlands
        • 15.3.8.7. Nordic Countries
        • 15.3.8.8. Poland
        • 15.3.8.9. Russia & CIS
        • 15.3.8.10. Rest of Europe
    • 15.4. Germany Infant Formula Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Product Type
      • 15.4.3. Form
      • 15.4.4. Stage/Age Group
      • 15.4.5. Ingredient Type
      • 15.4.6. Packaging Type
      • 15.4.7. Distribution Channel
      • 15.4.8. End-users
    • 15.5. United Kingdom Infant Formula Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Product Type
      • 15.5.3. Form
      • 15.5.4. Stage/Age Group
      • 15.5.5. Ingredient Type
      • 15.5.6. Packaging Type
      • 15.5.7. Distribution Channel
      • 15.5.8. End-users
    • 15.6. France Infant Formula Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Product Type
      • 15.6.3. Form
      • 15.6.4. Stage/Age Group
      • 15.6.5. Ingredient Type
      • 15.6.6. Packaging Type
      • 15.6.7. Distribution Channel
      • 15.6.8. End-users
    • 15.7. Italy Infant Formula Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Product Type
      • 15.7.3. Form
      • 15.7.4. Stage/Age Group
      • 15.7.5. Ingredient Type
      • 15.7.6. Packaging Type
      • 15.7.7. Distribution Channel
      • 15.7.8. End-users
    • 15.8. Spain Infant Formula Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Product Type
      • 15.8.3. Form
      • 15.8.4. Stage/Age Group
      • 15.8.5. Ingredient Type
      • 15.8.6. Packaging Type
      • 15.8.7. Distribution Channel
      • 15.8.8. End-users
    • 15.9. Netherlands Infant Formula Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Product Type
      • 15.9.3. Form
      • 15.9.4. Stage/Age Group
      • 15.9.5. Ingredient Type
      • 15.9.6. Packaging Type
      • 15.9.7. Distribution Channel
      • 15.9.8. End-users
    • 15.10. Nordic Countries Infant Formula Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Product Type
      • 15.10.3. Form
      • 15.10.4. Stage/Age Group
      • 15.10.5. Ingredient Type
      • 15.10.6. Packaging Type
      • 15.10.7. Distribution Channel
      • 15.10.8. End-users
    • 15.11. Poland Infant Formula Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Product Type
      • 15.11.3. Form
      • 15.11.4. Stage/Age Group
      • 15.11.5. Ingredient Type
      • 15.11.6. Packaging Type
      • 15.11.7. Distribution Channel
      • 15.11.8. End-users
    • 15.12. Russia & CIS Infant Formula Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Product Type
      • 15.12.3. Form
      • 15.12.4. Stage/Age Group
      • 15.12.5. Ingredient Type
      • 15.12.6. Packaging Type
      • 15.12.7. Distribution Channel
      • 15.12.8. End-users
    • 15.13. Rest of Europe Infant Formula Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Product Type
      • 15.13.3. Form
      • 15.13.4. Stage/Age Group
      • 15.13.5. Ingredient Type
      • 15.13.6. Packaging Type
      • 15.13.7. Distribution Channel
      • 15.13.8. End-users
  • 16. Asia Pacific Infant Formula Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. East Asia Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Product Type
      • 16.3.2. Form
      • 16.3.3. Stage/Age Group
      • 16.3.4. Ingredient Type
      • 16.3.5. Packaging Type
      • 16.3.6. Distribution Channel
      • 16.3.7. End-users
      • 16.3.8. Country
        • 16.3.8.1. China
        • 16.3.8.2. India
        • 16.3.8.3. Japan
        • 16.3.8.4. South Korea
        • 16.3.8.5. Australia and New Zealand
        • 16.3.8.6. Indonesia
        • 16.3.8.7. Malaysia
        • 16.3.8.8. Thailand
        • 16.3.8.9. Vietnam
        • 16.3.8.10. Rest of Asia Pacific
    • 16.4. China Infant Formula Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Form
      • 16.4.4. Stage/Age Group
      • 16.4.5. Ingredient Type
      • 16.4.6. Packaging Type
      • 16.4.7. Distribution Channel
      • 16.4.8. End-users
    • 16.5. India Infant Formula Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Form
      • 16.5.4. Stage/Age Group
      • 16.5.5. Ingredient Type
      • 16.5.6. Packaging Type
      • 16.5.7. Distribution Channel
      • 16.5.8. End-users
    • 16.6. Japan Infant Formula Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Form
      • 16.6.4. Stage/Age Group
      • 16.6.5. Ingredient Type
      • 16.6.6. Packaging Type
      • 16.6.7. Distribution Channel
      • 16.6.8. End-users
    • 16.7. South Korea Infant Formula Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Product Type
      • 16.7.3. Form
      • 16.7.4. Stage/Age Group
      • 16.7.5. Ingredient Type
      • 16.7.6. Packaging Type
      • 16.7.7. Distribution Channel
      • 16.7.8. End-users
    • 16.8. Australia and New Zealand Infant Formula Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Product Type
      • 16.8.3. Form
      • 16.8.4. Stage/Age Group
      • 16.8.5. Ingredient Type
      • 16.8.6. Packaging Type
      • 16.8.7. Distribution Channel
      • 16.8.8. End-users
    • 16.9. Indonesia Infant Formula Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Product Type
      • 16.9.3. Form
      • 16.9.4. Stage/Age Group
      • 16.9.5. Ingredient Type
      • 16.9.6. Packaging Type
      • 16.9.7. Distribution Channel
      • 16.9.8. End-users
    • 16.10. Malaysia Infant Formula Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Product Type
      • 16.10.3. Form
      • 16.10.4. Stage/Age Group
      • 16.10.5. Ingredient Type
      • 16.10.6. Packaging Type
      • 16.10.7. Distribution Channel
      • 16.10.8. End-users
    • 16.11. Thailand Infant Formula Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Product Type
      • 16.11.3. Form
      • 16.11.4. Stage/Age Group
      • 16.11.5. Ingredient Type
      • 16.11.6. Packaging Type
      • 16.11.7. Distribution Channel
      • 16.11.8. End-users
    • 16.12. Vietnam Infant Formula Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Product Type
      • 16.12.3. Form
      • 16.12.4. Stage/Age Group
      • 16.12.5. Ingredient Type
      • 16.12.6. Packaging Type
      • 16.12.7. Distribution Channel
      • 16.12.8. End-users
    • 16.13. Rest of Asia Pacific Infant Formula Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Product Type
      • 16.13.3. Form
      • 16.13.4. Stage/Age Group
      • 16.13.5. Ingredient Type
      • 16.13.6. Packaging Type
      • 16.13.7. Distribution Channel
      • 16.13.8. End-users
  • 17. Middle East Infant Formula Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Middle East Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Form
      • 17.3.3. Stage/Age Group
      • 17.3.4. Ingredient Type
      • 17.3.5. Packaging Type
      • 17.3.6. Distribution Channel
      • 17.3.7. End-users
      • 17.3.8. Country
        • 17.3.8.1. Turkey
        • 17.3.8.2. UAE
        • 17.3.8.3. Saudi Arabia
        • 17.3.8.4. Israel
        • 17.3.8.5. Rest of Middle East
    • 17.4. Turkey Infant Formula Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Form
      • 17.4.4. Stage/Age Group
      • 17.4.5. Ingredient Type
      • 17.4.6. Packaging Type
      • 17.4.7. Distribution Channel
      • 17.4.8. End-users
    • 17.5. UAE Infant Formula Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Form
      • 17.5.4. Stage/Age Group
      • 17.5.5. Ingredient Type
      • 17.5.6. Packaging Type
      • 17.5.7. Distribution Channel
      • 17.5.8. End-users
    • 17.6. Saudi Arabia Infant Formula Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Form
      • 17.6.4. Stage/Age Group
      • 17.6.5. Ingredient Type
      • 17.6.6. Packaging Type
      • 17.6.7. Distribution Channel
      • 17.6.8. End-users
    • 17.7. Israel Infant Formula Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Form
      • 17.7.4. Stage/Age Group
      • 17.7.5. Ingredient Type
      • 17.7.6. Packaging Type
      • 17.7.7. Distribution Channel
      • 17.7.8. End-users
    • 17.8. Rest of Middle East Infant Formula Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Form
      • 17.8.4. Stage/Age Group
      • 17.8.5. Ingredient Type
      • 17.8.6. Packaging Type
      • 17.8.7. Distribution Channel
      • 17.8.8. End-users
  • 18. Africa Infant Formula Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Africa Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Form
      • 18.3.3. Stage/Age Group
      • 18.3.4. Ingredient Type
      • 18.3.5. Packaging Type
      • 18.3.6. Distribution Channel
      • 18.3.7. End-users
      • 18.3.8. Country
        • 18.3.8.1. South Africa
        • 18.3.8.2. Egypt
        • 18.3.8.3. Nigeria
        • 18.3.8.4. Algeria
        • 18.3.8.5. Rest of Africa
    • 18.4. South Africa Infant Formula Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Form
      • 18.4.4. Stage/Age Group
      • 18.4.5. Ingredient Type
      • 18.4.6. Packaging Type
      • 18.4.7. Distribution Channel
      • 18.4.8. End-users
    • 18.5. Egypt Infant Formula Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Form
      • 18.5.4. Stage/Age Group
      • 18.5.5. Ingredient Type
      • 18.5.6. Packaging Type
      • 18.5.7. Distribution Channel
      • 18.5.8. End-users
    • 18.6. Nigeria Infant Formula Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Form
      • 18.6.4. Stage/Age Group
      • 18.6.5. Ingredient Type
      • 18.6.6. Packaging Type
      • 18.6.7. Distribution Channel
      • 18.6.8. End-users
    • 18.7. Algeria Infant Formula Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Product Type
      • 18.7.3. Form
      • 18.7.4. Stage/Age Group
      • 18.7.5. Ingredient Type
      • 18.7.6. Packaging Type
      • 18.7.7. Distribution Channel
      • 18.7.8. End-users
    • 18.8. Rest of Africa Infant Formula Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Product Type
      • 18.8.3. Form
      • 18.8.4. Stage/Age Group
      • 18.8.5. Ingredient Type
      • 18.8.6. Packaging Type
      • 18.8.7. Distribution Channel
      • 18.8.8. End-users
  • 19. South America Infant Formula Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Central and South Africa Infant Formula Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Product Type
      • 19.3.2. Form
      • 19.3.3. Stage/Age Group
      • 19.3.4. Ingredient Type
      • 19.3.5. Packaging Type
      • 19.3.6. Distribution Channel
      • 19.3.7. End-users
      • 19.3.8. Country
        • 19.3.8.1. Brazil
        • 19.3.8.2. Argentina
        • 19.3.8.3. Rest of South America
    • 19.4. Brazil Infant Formula Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Product Type
      • 19.4.3. Form
      • 19.4.4. Stage/Age Group
      • 19.4.5. Ingredient Type
      • 19.4.6. Packaging Type
      • 19.4.7. Distribution Channel
      • 19.4.8. End-users
    • 19.5. Argentina Infant Formula Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Product Type
      • 19.5.3. Form
      • 19.5.4. Stage/Age Group
      • 19.5.5. Ingredient Type
      • 19.5.6. Packaging Type
      • 19.5.7. Distribution Channel
      • 19.5.8. End-users
    • 19.6. Rest of South America Infant Formula Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Product Type
      • 19.6.3. Form
      • 19.6.4. Stage/Age Group
      • 19.6.5. Ingredient Type
      • 19.6.6. Packaging Type
      • 19.6.7. Distribution Channel
      • 19.6.8. End-users
  • 20. Key Players/ Company Profile
    • 20.1. Abbott Laboratories.
      • 20.1.1. Company Details/ Overview
      • 20.1.2. Company Financials
      • 20.1.3. Key Customers and Competitors
      • 20.1.4. Business/ Industry Portfolio
      • 20.1.5. Product Portfolio/ Specification Details
      • 20.1.6. Pricing Data
      • 20.1.7. Strategic Overview
      • 20.1.8. Recent Developments
    • 20.2. Arla Foods
    • 20.3. Beingmate Baby & Child Food Co., Ltd.
    • 20.4. Bellamy's Organic
    • 20.5. Biostime International Holdings Limited
    • 20.6. China Feihe Limited
    • 20.7. Dairy Farms International Holdings Ltd
    • 20.8. Danone S.A.
    • 20.9. Fonterra Co-operative Group Limited
    • 20.10. FrieslandCampina
    • 20.11. Hain Celestial Group
    • 20.12. HiPP GmbH & Co. Vertrieb KG
    • 20.13. Inner Mongolia Yili Industrial Group
    • 20.14. Meiji Holdings Co., Ltd.
    • 20.15. Morinaga Milk Industry Co., Ltd.
    • 20.16. Nestlé S.A.
    • 20.17. Perrigo Company plc
    • 20.18. Reckitt Benckiser Group plc
    • 20.19. Synutra International Inc.
    • 20.20. The Kraft Heinz Company
    • 20.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation